inclusion criteria: 1. male and female participants, aged ≥ 18 years. 2. participants who are hospitalised for suspected coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test or radiological confirmation. 3. participants with stable oxygen saturation (\>=94%) on supplementary oxygen 4. crp \>= 30 mg/l. 5. participants will have given their written informed consent to participate in the study and are able to comply with instructions and nebuliser.

inclusion criteria: 1. male and female participants, aged ≥ 18 years. 2. participants who are hospitalised for suspected coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test or radiological confirmation. 3. participants with stable oxygen saturation (\>=94%) on supplementary oxygen 4. crp \>= 30 mg/l. 5. participants will have given their written informed consent to participate in the study and are able to comply with instructions and nebuliser.

inclusion criteria: male and female participants, aged ≥ 18 years. participants who are hospitalised for suspected coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test or radiological confirmation. participants with stable oxygen saturation (>=94%) on supplementary oxygen crp >= 30 mg/l. participants will have given their written informed consent to participate in the study and are able to comply with instructions and nebuliser.

inclusion criteria: male and female participants, aged ≥ 18 years. participants who are hospitalised for suspected coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test or radiological confirmation. participants with stable oxygen saturation (>=94%) on supplementary oxygen crp >= 30 mg/l. participants will have given their written informed consent to participate in the study and are able to comply with instructions and nebuliser.

inclusion criteria: 1. male and female participants, aged ≥ 18 years. 2. participants who are hospitalised for suspected coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test or radiological confirmation. 3. participants with stable oxygen saturation (>=94%) on supplementary oxygen 4. crp >= 30 mg/l. 5. participants will have given their written informed consent to participate in the study and are able to comply with instructions and nebuliser.

inclusion criteria: 1. male and female participants, aged ≥ 18 years. 2. participants who are hospitalised for suspected coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test or radiological confirmation. 3. participants with stable oxygen saturation (>=94%) on supplementary oxygen 4. crp >= 30 mg/l. 5. participants will have given their written informed consent to participate in the study and are able to comply with instructions and nebuliser.